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ABSTRACT 
Objective 
To determine coverage of NHS Health Check, a national cardiovascular risk assessment programme 
in England, in the first four years after implementation, and to examine prevalence of high 
cardiovascular disease (CVD) risk and uptake of statins in high risk patients. 
Method 
Study sample was 95,571 patients in England aged 40-74 years continuously registered with 509 
practices in the Clinical Practice Research Datalink between April 2009 and March 2013. Multilevel 
logistic regression models were used to assess predictors of Health Check attendance; elevated CVD 
risk factors and statin prescribing among attendees.  
Results 
Programme coverage was 21.4% over four years, with large variations between practices (0%-72.7%) 
and regions (9.4%-30.7%). Coverage was higher in older patients (adjusted odds ratio 2.88, 95% 
confidence interval 2.49-3.31 for patients 70-74 years) and in patients with a family history of 
premature coronary heart disease (2.37, 2.22-2.53), but lower in Black Africans (0.75, 0.61-0.92) and 
Chinese (0.68, 0.47-0.96) compared with White British. Coverage was similar in patients living in 
deprived and affluent areas. Prevalence of high CVD risk (QRISK2≥20%) among attendees was 4.6% 
One third (33.6%) of attendees at high risk were prescribed a statin after Health Checks. 
Conclusions 
Coverage of the programme and statin prescribing in high risk individuals was low. Coverage was 
similar in deprived and affluent groups but lower in some ethnic minority groups, possibly widening 
inequalities. These findings raise a question about whether recommendations by WHO to develop 
CVD risk assessment programmes internationally will deliver anticipated health benefits. 
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HIGHLIGHTS 
 Coverage of the programme examined nationally was low in the first four years. 
 Wide variation in coverage was observed between practices and English regions.  
 Increases in statin prescribing were found in both high and lower risk patients. 
 Only 1/3 of attendees at high risk were prescribed a statin after Health Check. 
 Almost five times more patients at lower risk than high risk were offered a statin. 
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INTRODUCTION 
The burden of cardiovascular disease (CVD), type 2 diabetes mellitus and chronic kidney disease is 
substantial in developed countries and rising rapidly in developing countries.1 Despite downward 
secular trends, CVD remains the largest single cause of mortality in England, accounting for around 
34% of deaths annually.2 Cardiovascular disease also contributes significantly to health inequalities, 
with prevalence of risk factors, established disease, adverse health outcomes and premature death 
being disproportionately high in people in lower socio-economic classes and ethnic minority groups.2  
Many countries have begun prioritising cardiovascular risk assessment programmes with CVD 
prevention strategies, for instance the Million Hearts initiative in the United States and More Heart 
and Diabetes Checks in New Zealand.3 4 Recently the World Health Organisation published a global 
action plan for 2013-2020,5 with targets to achieve 25% relative reduction in premature mortality 
from non-communicable diseases including CVD and diabetes; and at least 50% of eligible people 
(aged 40 or above with a 10-year CVD risk ≥ 30%) to receive drug therapy and counselling by 2025.  
The National Health Service (NHS) Health Check programme implemented by the Department of 
Health in April 2009, invites all people in England aged 40-74 years, who are not currently on a 
vascular disease register, for a CVD risk assessment every five years. Attendees are communicated 
their CVD risk in a Health Check and provided with tailored risk management strategies and healthy 
lifestyle advice.  
Evaluation of the NHS Health Check programme is facilitated by the very high use of electronic 
health records in English primary care, though current evidence mostly comes from local studies with 
short follow up of patient outcomes. Therefore the main aim of this study was to evaluate coverage of 
the NHS Health Check programme nationally in the first four years following its implementation. 
Secondary aims were to assess the prevalence of cardiovascular risk factors and statin uptake among 
Health Check attendees. 
METHODS 
Data source 
We obtained a longitudinal dataset from the Clinical Practice Research Datalink (CPRD), one of the 
world‘s largest primary care databases. CPRD continuously collects anonymised electronic medical 
records from participating general practices in the United Kingdom,6 it is nationally representative and 
covers approximately 8% of the population.7 8 Recent research has found good validity in CPRD data, 
and the database has been extensively used in epidemiological studies and health services research.7 9 
The dataset contains information for patient visits using Read codes which support structural encoding 
of clinical medical records used by general practices in UK.10 CPRD also includes patient‘s 
demographic information, medical history, test results, treatments (including statin prescription and 
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brief interventions) and referrals to secondary care.6 Ethical approval for the study protocol was 
granted by the CPRD Independent Scientific Advisory Committee (protocol number: 12_039). 
Study sample 
A random sample of 300,000 age eligible patients was obtained from CPRD for the intervention 
period of April 1st 2009 (i.e. start date of the programme) to March 31st 2013. For the purposes of this 
study we employed the following exclusion criteria (Figure 1): not living in England; previous 
diagnosis of vascular disease before or during the study period (vascular disease exclusions were 
based on the NHS Health Check Exclusion Read Codes approved by the NHS Information Standards 
Board in July 2011);11 not aged between 40 and 74 years or alive throughout the study period; and not 
continuously registered with a general practice during the study period. Our exclusion criteria resulted 
in a final sample of 95,571 patients for our study. 
Outcome measures 
The primary outcome measure was Health Check coverage, defined as the proportion of total eligible 
population who attended a Health Check in the first four years after programme implementation. 
Although there has been some use of Read codes to record a Health Check attendance in general 
practices, their usage remained low until late in the study period (Appendix Table A). We therefore 
defined Health Check attendance, based on the Best Practice Guidance of the programme,12 by the 
measurement of four risk factors: blood pressure; body mass index; cholesterol ratio; and smoking 
status recorded within a six-month window during the intervention period. We built a search 
algorithm based on this definition with attendance date assigned when the last of four risk factors was 
recorded. We validated the algorithm against available Read coded Health Check data (Appendix 
Table A). The algorithm identified 84.9% of the Health Check attendances which were Read coded, 
and assigned 59.0% of the attendances on the same date, and 82.4% within six months from the Read 
coded Health Check date (Appendix Table B). 
Secondary outcome measures included levels of risk factors (blood pressure, body mass index, 
cholesterol, smoking status) and global CVD risk scores calculated by both National Institute for 
Health and Care Excellence (NICE) Framingham and QRISK2 algorithms at the time of Health 
Check, and whether patients attending a Health Check were prescribed a statin in the 12 months 
before and 12 months after completion of their Health Checks. Risk factor thresholds we used were ≥ 
140/90 mm Hg for elevated blood pressure, a body mass index of ≥ 30 kg/m2 for obesity, and ≥ 5 
mmol/l for raised total cholesterol. High CVD risk was defined as having a 20% or higher global 
CVD risk score. We generated CVD risk scores rather than using existing scores in the medical record 
as these were poorly recorded and were occasionally derived from old risk factor data. The NICE 
Framingham risk scores were calculated using the 1991 Framingham equation but adjusted by a factor 
of 1.4 for South Asian men and 1.5 for family history of premature coronary heart disease (CHD) as 
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per NICE lipid modification guidance.13 14 QRISK2 scores were generated using the QRISK2 batch 
processor, .NET version 2013.0, obtained from ClinRisk Limited. 
Smoking status was verified from patient records. Patients were assumed to be non-smokers if their 
medical record never indicated them being a smoker.15 Cholesterol ratio was calculated by the ratio of 
total cholesterol to high density lipoprotein cholesterol where high density lipoprotein cholesterol was 
assumed to be 1 mmol/l if missing.16 We assigned ethnicity as ―missing‖ if not recorded, and as 
having no family history of premature CHD if this was not recorded. Since CPRD only provides an 
individual‘s quintile of the Townsend (2001) deprivation index, we assigned the median Townsend 
score nationally for each quintile to calculate each patients‘ QRISK2 score.17 Patients with missing 
Townsend data (27.4%) were assigned a score of 0 as this is the default value in the QRISK2 
algorithm. We assigned patients as being on statins before Health Checks if they had a prescription in 
the 12 months prior to their first risk factor being recorded. Patients were defined as being on statins 
after Health Checks if they had a prescription within the 12 months after their algorithm generated 
Health Check date. 
Predictor variables 
Predictor variables were individual‘s age (40-49, 50-59, 60-69, 70-74) in 2009, gender, ethnicity, 
family history of premature CHD in a first degree relative, socioeconomic status based on quintile of 
the 2010 Index of Multiple Deprivations determined by practice postcode,18 and English region. 
Ethnicity groupings were built upon the 2001 Census categories as suggested in the Health Check 
secondary use dataset.19 We merged ethnic groups and age groups in some analyses as appropriate due 
to small sample size in some categories. Index of Multiple Deprivations is a summary measure of 
deprivation assigned to each Lower Layer Super Output Area in England.18 The index has combined 
measures from seven major deprivation domains (e.g. income, employment). We decided not to use 
patient Townsend data as our deprivation variable because 27.4% of data was missing. 
Statistical analysis 
We calculated the overall coverage for the programme in the first four years after implementation, and 
assessed unadjusted differences in Health Check coverage by population subgroup using two-tailed z-
tests for proportions. We calculated means, proportions and their respective 95% confidence intervals 
of risk factor levels and global CVD risk scores in Health Check attendees.  
We built multilevel logistic regression models to examine associations between Health Check 
attendance and potential predictors; between elevated risk factor levels and demographic 
characteristics; and between statin prescribing and predictor variables for high or lower CVD patients 
separately. 
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All logistic regression models used were first tested to determine if a two-level random intercept 
model was substantively better than a single-level model. Multilevel models were fitted with 
individuals nested within practices. Predictor variables were added into the model one at a time to 
assess their significance but variable selection was not applied. Significance of random slope was 
tested for each of the predictor variables. Better models were determined by a significant reduction in 
deviance compared to a chi-squared distribution with suitable degrees of freedom at 5% level. 
Multicollinearity was tested among independent variables but was not found. 
We present the final fitted models with their variance partition coefficient and median odds ratio 
calculated from their practice level variance. A higher variance partition coefficient suggests larger 
variation in the propensity of attending a Health Check between practices. Median odds ratio is 
directly comparable to the adjusted odds ratios presented in the fixed effect and its concept has been 
documented elsewhere.20 A median odds ratio of one means no differences in the probability of 
attending a Health Check. Data manipulation was performed in SAS version 9.3 and statistical 
analyses were conducted in STATA/SE version 12. 
RESULTS 
Variation in Health Check coverage 
Health Check coverage was 21.4% (20,409/95,571) during the first four years of the programme, with 
wide variations between general practices (0%-72.7%). Characteristics of Health Check eligible 
patients and programme coverage by patient subgroups are displayed in Table 1. There was 
significant variation in coverage between English regions from 9.4% in Yorkshire and Humber to 
30.7% in the North East.  
Adjusted results for coverage are also shown in Table 1. We observed a strong practice effect via the 
large median odds ratio (2.95) and variance partition coefficient (28%). Health Check coverage was 
significantly higher in older patients (adjusted odds ratio 2.88, 95% confidence interval 2.49 to 3.31 in 
those aged 70-74 years compared with those aged 40-49 years) and in those with a family history of 
CHD (2.37, 2.22 to 2.53). Compared with White British patients, patients who had no ethnicity 
recorded (0.18, 0.17 to 0.19) or preferred not to state it (0.47, 0.41 to 0.53); patients who were Black 
African (0.75, 0.61 to 0.92), Chinese (0.68, 0.47 to 0.96), or from other White (0.35, 0.33 to 0.37) or 
other Black backgrounds (0.58, 0.46 to 0.74) had significantly lower coverage. There was no 
significant difference in coverage observed by gender or by deprivation group.
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Table 1 Health Check eligible population characteristics and coverage in England (April 2009-March 
2013) 
  n Coverage AOR (95% CI) 
Gender    
Malea 45708 20.2% 1.00 
Female 49863 22.4%* 1.01 (0.98-1.05) 
Age group    
40-49a 44561 17.0% 1.00 
50-59 30494 22.4%* 1.60 (1.54-1.67) 
60-69 19331 29.0%* 2.47 (2.36-2.58) 
70-74 1185 31.2%* 2.88 (2.49-3.31) 
Family history of CHD    
Noa 90286 20.2% 1.00 
Yes 5285 41.6%* 2.37 (2.22-2.53) 
Ethnicity    
Britisha 28619 35.8% 1.00 
Irish 348 43.4%* 1.00 (0.79-1.27) 
Other White background 20687 20.2%* 0.35 (0.33-0.37) 
Indian 725 42.8%* 0.99 (0.83-1.17) 
Pakistani/Bangladeshi 348 44.5%* 1.08 (0.84-1.38) 
Other Asian background 450 42.0%* 1.07 (0.86-1.32) 
Caribbean 369 37.1% 0.84 (0.66-1.07) 
African 515 33.4% 0.75 (0.61-0.92) 
Other Black background 420 27.4%* 0.58 (0.46-0.74) 
Chinese 176 30.1% 0.68 (0.47-0.96) 
Othersb 625 36.8% 0.91 (0.76-1.09) 
Not stated 2354 22.0%* 0.47 (0.41-0.53) 
Missing 39935 9.9%* 0.18 (0.17-0.19) 
IMD quintile    
1 - Least depriveda 17236 21.8% 1.00 
2 20953 21.3% 0.79 (0.56-1.13) 
3 21152 19.0%* 0.72 (0.51-1.03) 
4 20001 21.3% 0.82 (0.58-1.17) 
5 - Most deprived 16229 24.0%* 0.91 (0.63-1.31) 
Region    
Londona 11827 28.5% 1.00 
North East 2064 30.7%* 0.90 (0.43-1.87) 
North West 13933 27.6% 1.09 (0.76-1.57) 
Yorkshire & The Humber 5852 9.4%* 0.11 (0.06-0.19) 
East Midlands 6053 10.8%* 0.24 (0.13-0.41) 
West Midlands 9922 23.8%* 0.77 (0.35-0.82) 
East of England 12156 17.3%* 0.54 (0.35-0.82) 
South West 9696 18.1%* 0.70 (0.46-1.04) 
South Central 12840 22.9%* 1.05 (0.70-1.57) 
South East Coast 11228 19.5%* 1.01 (0.69-1.49) 
Total 95571 21.4%  
Measures of clustering:    
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Practice level variance   1.30 (1.11-1.52) 
Median Odds Ratio   2.95 
Variance partition coefficient   0.28 
Notes: n=number eligible; Coverage=attended/eligible; AOR=adjusted odds ratio; CHD=coronary heart disease; 
IMD=index of multiple deprivation; AOR was adjusted by all the other variables in the model; a Reference 
group. b Others - mixed background (White and Black Caribbean, White and Black African, White and Asian, 
other mixed background) and others. *p<0.05 in z-test. 
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Risk factor levels in Health Check attendees 
Risk factor levels and global CVD risk scores in those who attended a Health Check are summarised 
in Table 2. More than one third (34.5%) of Health Check attendees had blood pressure ≥ 140/90 mm 
Hg, 26.3% were obese (≥ 30 kg/m2), 70.1% had total cholesterol ≥ 5 mmol/l, and 17.3% were current 
smokers. A total of 14.4% attendees were at high risk of CVD using the NICE Framingham equation 
and 4.6% using QRISK2. 
Predictors of elevated risk factors are shown in Table 3. Advanced age was associated with elevated 
blood pressure (1.99, 1.84 to 2.14 in those aged 60-74 years v patients aged 40-49 years) and raised 
total cholesterol (1.73, 1.60 to 1.87). In the contrary, an inverse association with increasing age was 
found for obesity (0.68, 0.62 to 0.73) and being a current smoker (0.58, 0.53 to 0.64). Having a family 
history of CHD was only significantly associated with a higher odds of having a total cholesterol ≥ 5 
mmol/l. 
Patients registered with practices in the most deprived quintile were significantly more likely to be 
current smokers (2.60, 2.19 to 3.09) and obese (1.32, 1.15 to 1.51) compared with those registered 
with practices from the least deprived quintile. Comparing with White patients, South Asian patients 
were significantly less likely to be obese (0.68, 0.56 to 0.84), less likely to be current smokers (0.40, 
0.30 to 0.52); and less likely to have raised blood pressure (0.73, 0.60 to 0.89). 
Table 4 shows demographic predictors of patients at high CVD risk determined by each of the risk 
algorithms, but results were similar. While all predictors were significant in the model, advanced age 
had the largest adjusted odds ratio (41.6, 32.8 to 52.8 in those aged 60-74 years v patients aged 40-59 
years), followed by having a family history of CHD compared to those without (6.54, 5.28 to 8.08). 
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Table 2 Risk factor level summary of Health Check attendees (n=20409) at their Health Checks between 
April 2009 and March 2013 in England 
Blood pressure   
 
Mean SBP (95%CI) 131.2 (131.05-131.51) 
 
Mean DBP (95%CI) 79.82 (79.68-79.96) 
 
>=140/90 mmHg 34.5% 
Body Mass Index   
 
Mean (95%CI) 27.4 (27.3-27.5) 
 
BMI >= 30 kg/m2  26.3% 
 
BMI >= 25 kg/m2 65.9% 
Total cholesterol   
 
Mean (95%CI) 5.54 (5.52-5.55) 
 
>= 6 mmol/l 33.1% 
  >= 5 mmol/l 70.1% 
HDL cholesterol   
 Mean (95%CI) 1.44 (1.42-1.45) 
Total/HDL ratio   
 Mean (95%CI) 4.16 (4.14-4.18) 
Smoking status   
 
Current smoker 17.3% 
CVD risk score   
 
QRISK2 mean (95%CI) 7.62 (7.53-7.70) 
 
QRISK2 >= 20% 4.6% 
 QRISK2 >= 10% 28.8% 
 
NICE Framingham mean (95%CI) 11.4 (11.3-11.5) 
  NICE Framingham >= 20% 14.4% 
Notes: SBP=systolic blood pressure; DBP=diastolic blood pressure; CI=confidence 
interval; HDL=high density lipoprotein; CVD=cardiovascular disease. 
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Table 3 Two-level multivariate logistic regression on risk factor thresholds among Health Check attendees (n=20409), Health Checks done between April 2009 and 
March 2013 in England 
   
BP≥140/90mm Hg BMI≥30kg/m2 TC≥5mmol/l Current smoker 
 n % attendees AOR AOR AOR AOR 
Gender 
      Male 9250 45.3% 1.00 1.00 1.00 1.00 
Female 11159 54.7% 0.63 (0.60-0.67) 1.04 (0.97-1.11) 1.20 (1.13-1.27) 0.79 (0.74-0.85) 
Age group     
 
      
40-49 7584 37.2% 1.00 1.00 1.00 1.00 
50-59 6841 33.5% 1.49 (1.38-1.60) 0.85 (0.79-0.92) 1.67 (1.55-1.80) 0.80 (0.73-0.87) 
60-74 5984 29.3% 1.99 (1.84-2.14) 0.68 (0.62-0.73) 1.73 (1.60-1.87) 0.58 (0.53-0.64) 
Family history of CHD     
    No 18210 89.2% 1.00 1.00 1.00 1.00 
Yes 2199 10.8% 0.98 (0.89-1.08) 1.06 (0.96-1.18) 1.17 (1.06-1.30) 0.99 (0.88-1.12) 
Ethnicitya     
 
      
 White  14562 71.4% 1.00 1.00 1.00 1.00 
 South Asian  654 3.2% 0.73 (0.60-0.89) 0.68 (0.56-0.84) 0.91 (0.77-1.09) 0.40 (0.30-0.52) 
 Black  424 2.1% 0.99 (0.79-1.24) 1.65 (1.33-2.03) 0.72 (0.58-0.89) 0.47 (0.34-0.63) 
 Others  283 1.4% 0.80 (0.61-1.05) 0.60 (0.44-0.82) 0.90 (0.70-1.17) 0.73 (0.52-1.02) 
 Not stated  519 2.5% 1.00 (0.82-1.22) 1.06 (0.86-1.31) 0.97 (0.79-1.19) 1.09 (0.86-1.40) 
 Missing  3967 19.4% 1.16 (1.07-1.26) 0.97 (0.89-1.06) 1.12 (1.03-1.22) 0.86 (0.77-0.96) 
IMD quintile       
   1 - Least deprived  3759 18.4% 1.00 1.00 1.00 1.00 
2 4457 21.8% 1.12 (0.98-1.28) 1.04 (0.91-1.20) 0.89 (0.78-1.01) 1.37 (1.15-1.63) 
3 4023 19.7% 1.08 (0.94-1.23) 1.19 (1.04-1.36) 0.91 (0.80-1.03) 1.60 (1.35-1.91) 
4 4267 20.9% 1.08 (0.94-1.23) 1.27 (1.11-1.45) 0.94 (0.83-1.07) 2.00 (1.69-2.37) 
5 - Most deprived 3903 19.1% 1.10 (0.96-1.27) 1.32 (1.15-1.51) 0.89 (0.78-1.02) 2.60 (2.19-3.09) 
Total 20409 100.0%         
Measures of clustering: 
      Practice level variance 
  
0.07 (0.05-0.10) 0.06 (0.04-0.09) 0.05 (0.03-0.08) 0.10 (0.07-0.14) 
Median Odds Ratio 
  
1.29 1.26 1.24 1.35 
Variance partition coefficient 
  
0.02 0.02 0.01 0.03 
Notes: BP=blood pressure; BMI=body mass index; TC=total cholesterol. AOR=adjusted odds ratio; IMD=index of multiple deprivation; CHD=coronary heart disease; AOR 
was adjusted by all the other variables in the model. Age group has been collapsed for 60-74 olds.  
a Ethnicity: White – British, Irish, Other White background; Others - mixed background (White and Black Caribbean, White and Black African, White and Asian, other 
mixed background), Chinese, other ethnic backgrounds; South Asian – Indian, Pakistani, Bangladeshi, Other Asian background; Black – Caribbean, African, Other black 
background.
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
13 
 
Table 4 Two-level multivariate logistic regression on global risk scores threshold among Health Check attendees (n=20409), Health Checks done between April 
2009 and March 2013 in England 
   NICE Framingham≥20% QRISK2≥20% 
  n % attendees AOR AOR 
Gender     
Male 9250 45.3% 1.00 1.00 
Female 11159 54.7% 0.07 (0.06-0.08) 0.08 (0.06-0.10) 
Age group       
40-59 14425 70.7% 1.00 1.00 
60-74 5984 29.3% 8.09 (7.30-8.90) 41.6 (32.8-52.8) 
Family history of CHD       
No 18210 89.2% 1.00 1.00 
Yes 2199 10.8% 4.54 (3.98-5.17) 6.54 (5.28-8.08) 
IMD quintile       
1 - Least deprived  3759 18.4% 1.00 1.00 
2 4457 21.8% 1.38 (1.14-1.67) 1.24 (0.93-1.66) 
3 4023 19.7% 1.27 (1.05-1.54) 1.43 (1.07-1.91) 
4 4267 20.9% 1.24 (1.02-1.51) 1.25 (0.93-1.68) 
5 - Most deprived 3903 19.1% 1.57 (1.29-1.91) 1.78 (1.32-2.39) 
Total 20409 100.0%     
Measures of clustering:     
Practice level variance   0.11 (0.07-0.17) 0.17 (0.09-0.32) 
Median Odds Ratio   1.37 1.48 
Variance partition coefficient   0.03 0.05 
Notes: AOR=adjusted odds ratio; IMD=index of multiple deprivation; CHD=coronary heart disease; AOR was adjusted by all the other variables in the model; Age group has 
been collapsed into 40-59 and 60-74 age groups.
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Statin prescribing before and after Health Checks 
Results for statin prescribing stratified by (QRISK2) high and lower CVD risk groups are presented in 
Table 5. A threefold increase in statin prescribing was observed in high risk patients (11.1% to 33.6%) 
while an approximately 1.5-times increase (7.0% to 11.7%) in statin prescribing were observed in 
lower risk patients after Health Check attendance. Most of the increase in statin prescribing seen in 
patients with lower global CVD risk occurred in those with high (≥ 5 mmol/l) total cholesterol (data 
not shown). In absolute terms, almost five times more lower risk patients were prescribed a statin after 
their Health Check than higher risk patients (1025/226). 
Family history of CHD was the only significant predictor of higher statin prescribing in high risk 
patients (1.43, 1.02 to 2.01). The strongest and most significant predictor of statin prescribing in the 
lower risk group was older age (3.19, 2.90 to 3.50 in 60-74 years v patients aged 40-59 years). Lower 
risk patients were significantly more likely to be prescribed statins if they had a family history of 
CHD (1.69, 1.47 to 1.95); or registered with practices in more deprived areas than those in the least 
deprived areas (1.36, 1.08 to 1.70 in the most deprived quintile). Similar results were obtained using 
NICE Framingham (Appendix Table C).
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
15 
 
Table 5 Statin prescribing in Health Check attendees (n=20409) by high or low CVD risk groups determined by QRISK2 scores, England 
 
QRISK2≥20% 
 
QRISK2<20% 
  n Prea AOR (95%CI) Postb AOR (95%CI)   n Prea AOR (95%CI) Postb AOR (95%CI) 
Gender 
       
  
 
  
 Male 803 11.7% 1.00 34.6% 1.00 
 
8447 7.8% 1.00 13.6% 1.00 
Female 140 7.8% 0.56 (0.28-1.12) 27.8% 0.70 (0.46-1.07)   11019 6.4% 0.70 (0.62-0.79) 10.3% 0.63 (0.57-0.69) 
Age group 
           40-59 90 12.2% 1.00 38.8% 1.00 
 
14335 4.6% 1.00 8.4% 1.00 
60-74 853 11.0% 1.29 (0.62-2.71) 33.0% 0.95 (0.58-1.54)   5131 13.4% 3.51 (3.12-3.94) 20.8% 3.19 (2.90-3.50) 
Family history of CHD 
         
  
 No 714 9.2% 1.00 31.7% 1.00 
 
17496 6.7% 1.00 11.4% 1.00 
Yes 229 17.0% 2.27 (1.40-3.70) 39.7% 1.43 (1.02-2.01)   1970 9.7% 1.90 (1.60-2.25) 14.9% 1.69 (1.47-1.95) 
IMD quintile 
           1 – Least deprived  142 7.8% 1.00 36.6% 1.00 
 
3617 6.6% 1.00 10.2% 1.00 
2 202 11.9% 1.82 (0.80-4.17) 29.7% 0.76 (0.47-1.25) 
 
4255 7.6% 1.20 (0.92-1.57) 11.6% 1.18 (0.95-1.48) 
3 212 9.0% 1.21 (0.52-2.82) 30.2% 0.75 (0.46-1.21) 
 
3811 6.7% 1.05 (0.80-1.38) 11.1% 1.13 (0.90-1.42) 
4 182 10.4% 1.47 (0.62-3.45) 29.1% 0.71 (0.43-1.18) 
 
4085 7.9% 1.29 (0.99-1.69) 13.4% 1.46 (1.17-1.82) 
5 – Most deprived 205 15.6% 2.18 (0.98-4.85) 42.9% 1.27 (0.79-2.04) 
 
3698 6.1% 1.02 (0.77-1.35) 12.2% 1.36 (1.08-1.70) 
Total 943 11.1% 
 
33.6% 
 
  19466 7.0% 
 
11.7% 
 Measures of clustering: 
           Practice level variance 
  
0.41 (0.06-2.54) 
 
0.11 (0.009-1.35)  
  
0.33 (0.24-0.45) 
 
0.24 (0.18-0.32) 
Median Odds Ratio 
  
1.84 
 
1.37 
   
1.73 
 
1.59 
Variance partition coefficient 
  
0.11 
 
0.03 
   
0.09 
 
0.07 
Notes: AOR=adjusted odds ratio; IMD=index of multiple deprivation; CHD=coronary heart disease; AOR was adjusted by all the other variables in the model; Age group has 
been collapsed into 40-59 and 60-74 age groups. 
a Before Health Check. 
b After Health Check.
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DISCUSSION 
Key findings and comparison with other studies 
Coverage of the NHS Health Check programme was low at 21.4% in the first four years after 
programme implementation. Coverage ranged from 9.4% to 30.7% between English regions, and 
varied widely between general practices (0%-72.7%). The large variation in coverage present is 
consistent with previous studies and may reflect the phased initial roll-out of the programme.21-23 Our 
findings are consistent with previous local studies which found higher attendance in older patients and 
in those with a family history of CHD.22-24 Previous studies suggest attendance may be higher in 
ethnic minority groups but have produced mixed findings on whether men or women were more likely 
to attend.22-24 We identified no significant gender differences in coverage using national data. Our 
large sample size allowed us to assess coverage by ethnic group in greater detail than previous studies. 
We found significantly lower coverage in patients from Black African; other Black; Chinese and 
Other ethnic groups when compared with White British. Importantly, we found no difference in 
coverage between patients living in deprived and affluent areas of England. In addition, we did not 
find any pattern suggesting a relationship between coverage of the English regions and the proportion 
of high risk patients identified (results not shown). 
Health Check attendees in our study had lower risk factor levels than those found in previous studies 
as those evaluated local programmes which initially targeted patients at high CVD risk.22 23 Risk 
factor levels in our sample were broadly similar to nationally representative estimates derived from 
the Health Survey for England, which found that 32.8% of respondents had elevated blood pressure, 
29.3% were obese and 19.8% smoked.25 Our findings on statin prescribing activity are consistent with 
previous studies which report underuse of statins in high risk patients with potential overuse in lower 
risk patients. Statin prescribing in patients with lower global CVD risk was higher in patients with 
higher total cholesterol, older patients and those with  a family history of CHD which is consistent 
with previous studies.8 22 23 26 27 Despite a threefold increase in the number of high risk patients 
prescribed statins, our findings suggest only one in three (33.6%) high risk patients were prescribed a 
statin after their Health Checks. The use of statins for primary prevention of CVD has been subject to 
much debate.28 29 The recent update of the lipid guidance NICE has lowered the risk threshold to 
10%.30 Based on our QRISK2 data this would make one third of Health Check attendees potentially 
eligible for a statin therapy.   
Strengths and limitations of this study 
This study is the first to evaluate national coverage of the NHS Health Check programme. Using 
CPRD data allows nationally representative estimates of programme performance, including the 
examination of patient, practice and regional level variations in coverage and risk factor management. 
However, our study has highlighted poor recording of Health Check invitation and attendance Read 
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codes in general practice data. Lack of data on invitations offered meant that we were only able to 
quantify programme coverage, not uptake. We restricted our sample to persons without vascular 
disease, registered with a CPRD practice and eligible for a Health Check throughout the study period. 
While our study design provides a robust and fair assessment of performance against programme 
objectives, it precludes us reporting incident cases of CVD, diabetes or chronic kidney disease 
identified as a result of Health Checks. However, screening for diabetes and chronic kidney disease 
were not core components of the programme during the study period. Our findings are restricted to 
patients who were continuously registered with participating practices during the first four years of 
Health Checks (2009-13), but were substantially unchanged when we included patients who were 
registered for only part of this time period (results not shown). People who were prescribed statins 
before their Health Check were not excluded in this study as this was not an eligibility criterion listed 
in the 2009 Best Practice Guidance.12 
Due to the large size of sample we obtained, we were able to compare coverage by more detailed 
ethnic categories than in previous work, but the study is limited by 41.8% of the patients with no 
ethnicity status recorded.  This ‗missing‘ category should not be interpreted as a distinctive group but 
rather an indication that these patients either consulted their general practices infrequently or were 
registered with practices with lower recording of ethnicity. We defined Health Check attendance by 
the measurement of four risk factors (blood pressure, body mass index, cholesterol ratio, smoking 
status) within a six-month window. Our validation of this algorithm showed it captured 84.9% of the 
Health Check attendances recorded using Read codes. However, there is still no single standard Read 
code for Health Check attendance. Individual level deprivation measures (based on patient‘s area of 
residence) were not available for 27.4% of the study sample. This meant we had to assign Index of 
Multiple Deprivation 2010 quintiles based on practice postcode for our deprivation predictor variable 
and assigned a default value for Townsend scores in QRISK2 calculations in these patients. 
Adherence to statins could not be examined in this study as CPRD only provides data on drug 
prescriptions by general practitioners but not on drug collection and use by patients. 
CONCLUSIONS  
Coverage of the NHS Health Check programme and statin prescribing in high risk individuals was 
low in the first four years of the programme. Substantial work needs to be undertaken to standardise 
operating procedures for the programme, to raise awareness about potential benefits among the public 
and NHS professionals, and to reduce barriers to attendance. Our finding of very low programme 
coverage and statin prescribing in a health system with universal health coverage and well developed 
primary care raise a question about whether plans to develop CVD risk assessment programmes 
internationally, as recently recommended   by the WHO,31 will deliver the anticipated public health 
benefits. 
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APPENDIX 
Table A - NHS Health Check related attendance/follow-up READ codes used by CPRD 
practices (based on 95571 Health Check eligible patients) 
READ 
code 
READ term 2009/10 2010/11 2011/12 2012/13 Total 
9NdT.11 Consent given for CV health check - - - 1 1 
9NdT.00 Consent given for CV health risk assessment - - 5 2 7 
8BAg.00 NHS Health Check completed 35 625 2078 3019 5757 
8BR2.00 NHS Health Check indicated - 61 134 339 534 
6B5..00 NHS Health Check programme - 209 204 409 822 
38B1.11 CVD risk assessment 9 15 5 - 29 
9OhA.00 CVD risk assessment done 231 746 668 379 2024 
8BR1.00 CVD risk assessment indicated 37 46 87 61 231 
38B1000 CVD risk assessment by third party - 3 32 31 66 
68...11 Screening - health check 31 59 31 24 145 
38B1.00 Vascular disease risk assessment 197 322 235 193 947 
6AH..00 NHS Health Check annual review 1 2 63 98 164 
Total   541 2088 3542 4556 10727 
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Table B – Health Check search algorithm validation (based on 10727 READ coded Health 
Checks from Table A) 
 Risk factors clustering period 
 6 Months 3 Months 
Number of RCHC identified by AGHC 9112 8823 
Proportion RCHC identified by AGHC 84.9% 82.3% 
--For those RCHCs identified by AGHC-- 
AGHC date = RCHC date 5379 5417 
  59.0% 61.4% 
Health Check dates diff <= 3 months 7271 7264 
  79.8% 82.3% 
Health Check dates diff <= 6 months 7512 7445 
  82.4% 84.4% 
Notes: RCHC – Read coded Health Check; AGHC – algorithm generated Health Check; 
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Table C - Statin prescribing in Health Check attendees by high or low CVD risk groups determined by NICE Framingham scores 
 
NICE Framingham≥20%  NICE Framingham<20% 
 
n Pre AOR (95%CI) Post AOR (95%CI)  n Pre AOR (95%CI) Post AOR (95%CI) 
Gender 
     
 
     Male 2442 9.5% 1.00 27.6% 1.00  6808 7.6% 1.00 11.1% 1.00 
Female 455 7.2% 0.58 (0.39-0.86) 29.5% 1.04 (0.82-1.32)  10704 6.4% 0.65 (0.57-0.74) 9.7% 0.70 (0.63-0.78) 
Age group 
     
 
     40-59 1116 6.7% 1.00 24.4% 1.00  12352 4.5% 1.00 7.3% 1.00 
60-74 1781 10.7% 1.95 (1.46-2.61) 30.1% 1.42 (1.18-1.71)  642 14.0% 3.96 (3.48-4.49) 19.3% 3.45 (3.10-3.84) 
Family history of CHD 
     
 
     No 2308 8.1% 1.00 27.3% 1.00  15902 6.6% 1.00 10.0% 1.00 
Yes 589 13.4% 2.12 (1.57-2.87) 30.2% 1.21 (0.97-1.50)  1610 9.4% 1.93 (1.59-2.34) 12.9% 1.68 (1.42-1.99) 
IMD quintile 
     
 
     1 - Least deprived 461 7.4% 1.00 24.3% 1.00  3298 6.5% 1.00 9.4% 1.00 
2 664 9.8% 1.42 (0.89-2.27) 25.0% 1.09 (0.78-1.54)  3793 7.4% 1.19 (0.90-1.57) 10.2% 1.11 (0.87-1.41) 
3 596 8.4% 1.16 (0.71-1.88) 26.9% 1.19 (0.84-1.68)  3427 6.5% 1.02 (0.77-1.37) 9.6% 1.01 (0.79-1.30) 
4 578 9.5% 1.42 (0.87-2.29) 27.5% 1.25 (0.88-1.77)  3689 7.7% 1.27 (0.96-1.68) 12.0% 1.37 (1.08-1.75) 
5 - Most deprived 598 10.4% 1.54 (0.96-2.48) 35.5% 1.87 (1.33-2.63)  3305 5.9% 0.98 (0.73-1.32) 9.9% 1.14 (0.89-1.47) 
Total 2897 8.8% 
 
27.9% 
 
 17512 6.9% 
 
10.2% 
 Measures of clustering: 
     
 
     Practice level variance 
  
0.16 (0.03-0.78) 
 
0.26 (0.14-0.47)  
  
0.35 (0.25-0.48) 
 
0.28 (0.21-0.38) 
Median Odds Ratio 
  
1.46 
 
1.62  
  
1.75 
 
1.65 
Variance partition coefficient 
  
0.05 
 
0.07  
  
0.10 
 
0.08 
Notes: AOR=adjusted odds ratio; IMD=index of multiple deprivation; CHD=coronary heart disease; AOR was adjusted by all the other variables in the model; Age group has 
been collapsed into 40-59 and 60-74 age groups. 
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Figure 1 Exclusions from the study sample 
Random sample of 
300,000 patients 
239,880 patients 
Exclude 60,120 patients not 
resident in England 
  
Exclude 72,921 patients who 
had a vascular disease 
diagnosis prior to 
31/03/2013 
  
166,959 patients 
Exclude 30,890 patients not 
aged in between 40-74 
throughout study period 
01/04/2009 to 31/03/2013 
  
136,069 patients 
Exclude 2,079 patients who 
died on or before 
31/03/2013 
  133,990 patients 
Exclude 38,419 patients who 
were not continuously 
registered throughout the 
study period 
  
95,571 patients 
(study population) 
 
